about
Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC).Mechanisms of tumor-promoting activities of nicotine in lung cancer: synergistic effects of cell membrane and mitochondrial nicotinic acetylcholine receptors.Pazopanib diminishes non-small cell lung cancer (NSCLC) growth and metastases in vivoLung Infection by Human Bocavirus Induces the Release of Profibrotic Mediator Cytokines In Vivo and In VitroThe prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).IL-17 Promotes Angiogenic Factors IL-6, IL-8, and Vegf Production via Stat1 in Lung Adenocarcinoma.Efficacy of motesanib diphosphate in non-small-cell lung cancer.Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations.Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells.Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells.Study of angiogenic signaling pathways in hemangioblastoma.MicroRNA-222 promotes human non-small cell lung cancer H460 growth by targeting p27.Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity.The crucial role of miR-126 on suppressing progression of esophageal cancer by targeting VEGF-A.Blocked expression of key genes of the angiogenic pathway in JSRV-induced pulmonary adenocarcinomas.A Purified Serine Protease from Nereis virens and Its Impaction of Apoptosis on Human Lung Cancer Cells.VEGF as a potential target in lung cancer.Endostatin reverses immunosuppression of the tumor microenvironment in lung carcinoma.Molecular Mechanisms Underlying the Inhibitory Effects of Qingzaojiufei Decoction on Tumor Growth in Lewis Lung Carcinoma.In Vitro Assays for Endothelial Cell Functions Required for Angiogenesis: Proliferation, Motility, Tubular Differentiation, and Matrix Proteolysis.Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis.
P2860
Q26775394-B8F61AFF-3076-4C7A-B1AE-66E3474248F6Q35204294-5B59DD57-910C-4865-B312-2B4BF1DEAADBQ35663577-F41C8E79-EFE7-4A29-AAD0-497AD3FEEDB3Q35903156-0630849A-CAD6-4952-9466-F7498EF3195DQ36557136-314EBEB3-DF9E-4521-938B-A415BC314D6FQ37397237-8BB0062C-616B-4520-ADC8-B21D3490A0A0Q38230556-758F4D9C-6836-453E-BFEA-AD521E010148Q38250467-CCC1391E-301E-4490-94F1-A76CF44724DEQ38722538-024F8A49-C620-4684-993C-426CEADE9C2AQ38821641-3C95643A-4610-42E3-B2B8-2C5F1F145075Q38844258-F2BE0AE7-6BF8-4C7A-966E-E3017723D6ECQ38858232-04A8A679-C191-4A5E-AD94-95BDC026EBD9Q39458295-BCE97ABF-2BBD-4A56-ADA4-B2548355CC10Q42128295-53EF825F-EA3E-45C2-A17A-29DF1F8BA934Q46135402-9F106A01-3EF4-4AA7-8CA8-2DD3DC86ADB4Q47572812-E469DAA9-50E6-4350-9666-A59C66DEA9B0Q47918409-BA458791-F052-45A9-9873-EC2227E7041FQ49622371-1AF1779B-0707-4CCD-A8AF-C0F8242C2DD0Q50943660-7CF3270F-EAD8-4D9D-AB32-BD3B52C2D344Q53097666-F1F751D0-C7E9-4311-9FBD-82F06AF8FF77Q55710778-15C67144-52D3-4382-8721-92D193D60F1F
P2860
description
2013 թվականի հոկտեմբերի 2-ին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
name
The VEGF pathway in lung cancer.
@en
type
label
The VEGF pathway in lung cancer.
@en
prefLabel
The VEGF pathway in lung cancer.
@en
P2093
P2860
P1476
The VEGF pathway in lung cancer.
@en
P2093
Konstantinos N Syrigos
Michalis Alevizakos
Serafim Kaltsas
P2860
P2888
P304
P356
10.1007/S00280-013-2298-3
P577
2013-10-02T00:00:00Z
P6179
1000213229